Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report

被引:0
|
作者
Nakahara, Seiji [1 ]
Doi, Shunsuke [1 ]
Nishiwada, Satoshi [1 ]
Yasuda, Satoshi [1 ]
Nagai, Minako [1 ]
Nakamura, Kota [1 ]
Matsuo, Yasuko [1 ]
Terai, Taichi [1 ]
Kohara, Yuichiro [1 ]
Sakata, Takeshi [1 ]
Nitta, Yuji [2 ]
Morita, Kohei [2 ]
Sho, Masayuki [1 ]
机构
[1] Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan
[2] Nara Med Univ, Dept Diagnost Pathol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan
关键词
Pancreatic ductal adenocarcinoma; Pancreatic lipoma; Pancreatic liposarcoma; Chronic pancreatitis; CANCER;
D O I
10.1186/s40792-023-01720-w
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPancreatic lipomas (PLs) arising from the adipose tissue in the pancreatic parenchyma are rare among pancreatic tumors. Coexisting pancreatic ductal adenocarcinoma (PDAC) and PLs have not been previously reported. Herein, we report a case of PDAC arising from the pancreatic parenchyma with chronic pancreatitis compressed by a large PL.Case presentationThe patient was a 69-year-old male. He had been diagnosed with a PL using computed tomography (CT) 12 years previously. The tumor had been slowly growing and was followed up carefully because of the possibility of well-differentiated liposarcoma. During follow-up, laboratory data revealed liver damage and slightly elevated levels of inflammatory markers. Contrast-enhanced CT revealed the previously diagnosed 12 cm pancreatic head tumor and an irregular isodensity mass at the upper margin of the tumor that invaded and obstructed the distal common bile duct. Magnetic resonance cholangiopancreatography demonstrated no specific findings in the main pancreatic duct. Based on these imaging findings, the patient underwent endoscopic retrograde biliary drainage and bile duct brushing cytology, which revealed indeterminate findings. The differential diagnosis of the tumor at that time was as follows: (1) pancreatic liposarcoma (focal change from well-differentiated to dedifferentiated, not lipoma), (2) distal cholangiocarcinoma, and (3) pancreatic cancer. After the cholangitis improved, a pancreatoduodenectomy was performed. Histologically, hematoxylin-eosin staining revealed moderately differentiated PDAC compressed by proliferating adipose tissue. The adipose lesion showed homogeneous adipose tissue with no evidence of sarcoma, which led to a diagnosis of lipoma. Additionally, extensive fibrosis of the pancreatic parenchyma and atrophy of the acinar cells around the lipoma was suggestive of chronic pancreatitis. The pathological diagnosis was PDAC (pT2N0M0 pStage Ib) with chronic pancreatitis and PL. The postoperative course was uneventful, and the patient was discharged on the 15th day after surgery. The patient received adjuvant chemotherapy and has remained recurrence-free for more than 6 months.ConclusionsPL may be associated with the development of PDAC in the surrounding inflammatory microenvironment of chronic pancreatitis. In cases of growing lipomas, careful radiologic surveillance may be needed not only for the possibility of liposarcoma but also for the coincidental occurrence of PDAC.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] A Case Report of Pancreatic Lipoma: Diagnosis with EUS
    Rattan, Sushil
    Venner, Allison
    Johnson, Lynt
    Haddad, Nadim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S211 - S212
  • [32] EUS diagnosis of pancreatic lipoma: a case report
    Di Matteo, FM
    Shimpi, L
    Pandolfi, M
    Rabitti, C
    Fabio, C
    Gabbrielli, A
    Costamagna, G
    GASTROINTESTINAL ENDOSCOPY, 2006, 64 (01) : 146 - 148
  • [33] Macrophages and pancreatic ductal adenocarcinoma
    Habtezion, Aida
    Edderkaoui, Mouad
    Pandol, Stephen J.
    CANCER LETTERS, 2016, 381 (01) : 211 - 216
  • [34] Staging of pancreatic ductal adenocarcinoma
    Sauvanet, A
    Zins, M
    JOURNAL DE CHIRURGIE, 1998, 135 (01): : 10 - 16
  • [35] Surgery for pancreatic ductal adenocarcinoma
    Vera, R.
    Diez, L.
    Martin Perez, E.
    Plaza, J. C.
    Sanjuanbenito, A.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (11): : 1303 - 1311
  • [36] Models of pancreatic ductal adenocarcinoma
    Dennaoui, Rayane
    Shrestha, Hridaya
    Wagner, Kay-Uwe
    CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 803 - 818
  • [37] MicroRNAs in pancreatic ductal adenocarcinoma
    Park, Jong Y.
    Helm, James
    Coppola, Domenico
    Kim, Donghwa
    Malafa, Mokenge
    Kim, Seung Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (07) : 817 - 827
  • [38] Hypoxia and pancreatic ductal adenocarcinoma
    Yamasaki, Akio
    Yanai, Kosuke
    Onishi, Hideya
    CANCER LETTERS, 2020, 484 : 9 - 15
  • [39] FOLFIRINOX for Pancreatic Ductal Adenocarcinoma
    Alakus, Hakan
    Korenkov, Michael
    Kuetting, Fabian
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (08): : 726 - 727
  • [40] Immunotherapy for pancreatic ductal adenocarcinoma
    Carpenter, Eileen
    Nelson, Sarah
    Bednar, Filip
    Cho, Clifford
    Nathan, Hari
    Sahai, Vaibhav
    di Magliano, Marina Pasca
    Frankel, Timothy L.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 751 - 759